Abordagem Fisioterapêutica na Esclerose Lateral Amiotrófica:

Artigo de Atualização

Autores

  • Eduardo Linden Junior Fisioterapeuta, Mestre em Ciências da Saúde, Área de Concentração em Neurociências, pela Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brasil. Consultório de Doenças Neuromusculares, Taquara, Rio Grande do Sul, Brasil.

DOI:

https://doi.org/10.34024/rnc.2013.v21.8188

Palavras-chave:

Esclerose Lateral Amiotrófica, Doença do Neurônio Motor, Fisioterapia, Reabilitação

Resumo

Introdução. Esclerose lateral amiotrófica é uma doença neurodegene­rativa em que o sistema motor é tipicamente o primeiro e o mais dras­ticamente afetado. De causa ainda desconhecida, é uma doença inva­riavelmente fatal com sérias repercussões para pacientes, cuidadores, familiares e profissionais envolvidos. Objetivo. O objetivo desta revi­são é conhecer o estado da arte acerca da abordagem fisioterapêutica na esclerose lateral amiotrófica. Método. Foi realizada uma revisão da literatura nas bases de dados SciELO, LILACS e MEDLINE e inclu­ídos no artigo os estudos mais relevantes. Resultados. Os resultados mostram que a fisioterapia tem um papel importante no tratamento dos pacientes com esclerose lateral amiotrófica. Conclusão. Através de métodos e técnicas fisioterapêuticas, é possível melhorar a qualidade de vida e prolongar a sobrevivência destes pacientes, principalmente através de exercício terapêutico e suporte respiratório.

Métricas

Carregando Métricas ...

Downloads

Não há dados estatísticos.

Referências

Amato AA, Russel JA. Neuromuscular disorders. New York: McGraw-Hill; 2008, 775p.

Chancellor AM, Warlow CP. Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950. J Neurol Neurosurg Psychiatry 1992;55:1106-15. http://dx.doi.org/10.1136/jnnp.55.12.11061.Amato AA, Russel JA. Neuromuscular disorders. New York: McGraw-Hill; 2008, 775p.

Chancellor AM, Warlow CP. Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950. J Neurol Neurosurg Psychiatry 1992;55:1106-15. http://dx.doi.org/10.1136/jnnp.55.12.1106

Logroscino G, Traynor BJ, Hardiman O, Chiò A, Couratier P, Mitchell JD, et al. J Neurol Neurosurg Psychiatry 2008;79:6-11. http://dx.doi.org/10.1136/jnnp.2006.104828

Wijesekera LC, Leigh PN. Amyotrophic lateral sclerosis. Orphanet J Rare Dis 2009;4:1-22. http://dx.doi.org/10.1186/1750-1172-4-3

Damme PV, Robberecht W. Recent advances in motor neuron disease. Curr Opin Neurol 2009;22:486-92. http://dx.doi.org/10.1097/WCO.0b013e32832ffbe3

Rothstein JD. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol 2009;65:S3-9. http://dx.doi.org/10.1002/ana.21543

Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-99. http://dx.doi.org/10.1080/146608200300079536

Mitchell JD, Borasio GD. Amyotrophic lateral sclerosis. Lancet 2007;369:2031-41. http://dx.doi.org/10.1016/S0140-6736(07)60944-1

Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000. J Neurol Neurosurg Psychiatry 2003;74:1258-61. http://dx.doi.org/10.1136/jnnp.74.9.1258

Chiò A, Bottacchi E, Buffa C, Mutani R, Mora G. Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities. J Neurol Neurosurg Psychiatry 2006;77:948-50. http://dx.doi.org/10.1136/jnnp.2005.083402

Van den Berg JP, Kalmijn S, Lindeman E, Veldink JH, Visser M, Van der Graaff MM, et al. Multidisciplinary ALS care improves quality of life in patients with ALS. Neurology 2005;65:1264-67. http://dx.doi.org/10.1212/01.wnl.0000180717.29273.12

Radunovic A, Mitsumoto H, Leigh PN. Clinical care of patients with amyotrophic lateral sclerosis. Lancet Neurol 2007;6:913-25. http://dx.doi.org/10.1016/S1474-4422(07)70244-2

Chen A, Montes J, Mitsumoto H. The role of exercise in amyotrophic lateral sclerosis. Phys Med Rehabil Clin N Am 2008;19:545-57. http://dx.doi.org/10.1016/j.pmr.2008.02.003

Mayadev AS, Weiss MD, Distad BJ, Krivickas LS, Carter GT. The amyotrophic lateral sclerosis center: a model of multidisciplinary management. Phys Med Rehabil Clin N Am 2008;19:619-31. http://dx.doi.org/10.1016/j.pmr.2008.04.004

Trail M, Nelson N, Van JN, Appel SH, Lai EC. Wheelchair use by patients with amyotrophic lateral sclerosis: a survey of user characteristics and selection preferences. Arch Phys Med Rehabil 2001;82:98-102. http://dx.doi.org/10.1053/apmr.2001.18062

Lewis M, Rushanan S. The role of physical therapy and occupational therapy in the treatment of amyotrophic lateral sclerosis. NeuroRehabilitation 2007;22:451-61.

Kisner C, Colby LA. Therapeutic exercise: foundations and techniques. 5th edition. Philadelphia: F.A. Davis; 2007, 1056p.

Dal Bello-Haas V, Florence JM, Krivickas LS. Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease. Cochrane Database Syst Rev 2008;Apr 16(2):CD005229. http://dx.doi.org/10.1002/14651858.CD005229.pub2

Drory VE, Goltsman E, Reznik JG, Mosek A, Korczyn AD. The value of muscle exercise in patients with amyotrophic lateral sclerosis. J Neurol Sci 2001;191:133-37. http://dx.doi.org/10.1016/S0022-510X(01)00610-4

Dal Bello-Haas V, Florence JM, Kloos AD, Scheirbecker J, Lopate G, Hayes SM, et al. A randomized controlled trial of resistance exercise in individuals with ALS. Neurology 2007;68:2003-07. http://dx.doi.org/10.1212/01.wnl.0000264418.92308.a4

Lui AJ, Byl NN. A systematic review of the effect of moderate intensity exercise on function and disease progression in amyotrophic lateral sclerosis. J Neurol Phys Ther 2009;33:68-87.

Groenestijn AC, Port IGL, Schröder CD, Post MWM, Grupstra HF, Kruitwagen ET, et al. Effects of aerobic exercise therapy and cognitive behavioral therapy on functioning and quality of life in amyotrophic lateral sclerosis: protocol of the FACTS-2-ALS trial. BMC Neurol 2011;11:70. http://dx.doi.org/10.1186/1471-2377-11-70

Siciliano G, Pastorini E, Pasquali L, Manca ML, Iudice A, Murri L. Impaired oxidative metabolism in exercising muscle from ALS patients. J Neurol Sci 2001;191:61-65. http://dx.doi.org/10.1016/S0022-510X(01)00620-7

Siciliano G, D´Avino C, Del Corona A, Barsacchi R, Kusmic C, Rocchi A, et al. impaired oxidative metabolism and lipid peroxidation in exercising muscle from ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord 2002;3:57-62. http://dx.doi.org/10.1080/146608202760196011

Heffernan C, Jenkinson C, Holmes T, Macleod H, Kinnear W, Oliver D, et al. Management of respiration in MND/ALS patients: an evidence based review. Amyotroph Lateral Scler 2006;7:5-15. http://dx.doi.org/10.1080/14660820510043235

Simonds AK. Recent advances in respiratory care for neuromuscular disease. Chest 2006;130:1879-86. http://dx.doi.org/10.1378/chest.130.6.1879

Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review). Neurology 2009;73:1218-26. http://dx.doi.org/10.1212/WNL.0b013e3181bc0141

Piepers S, Van den Berg JP, Kalmijn S, Van der Pol W, Wokke JHJ, Lindeman E, et al. Effect of non-invasive ventilation on survival, quality of life, respiratory function and cognition: a review of the literature. Amyotroph Lateral Scler 2006;7:195-200. http://dx.doi.org/10.1080/14660820500514974

Corcia P, Meininger V. Management of amyotrophic lateral sclerosis. Drugs 2008;68:1037-48. http://dx.doi.org/10.2165/00003495-200868080-00003

Baumann F, Henderson RD, Morrison SC, Brown M, Hutchinson N, Douglas JA, et al. Use of respiratory function tests to predict survival in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2010;11:194-202. http://dx.doi.org/10.3109/17482960902991773

Melo J, Homma A, Iturriaga E, Frierson L, Amato A, Anzueto A, et al. Pulmonary evaluation and prevalence of non-invasive ventilation in patients with amyotrophic lateral sclerosis: a multicenter survey and proposal of a pulmonary protocol. J Neurol Sci 1999;169:114-17. http://dx.doi.org/10.1016/S0022-510X(99)00228-2

Czaplinski A, Yen AA, Appel SH. Forced vital capacity (FVC) as an indication of survival and disease progression in an ALS clinic population. J Neurol Neurosurg Psychiatry 2006;77:390-92. http://dx.doi.org/10.1136/jnnp.2005.072660

Bourke SC, Tamlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ. Effects of non-invasive ventilation on survival and quality of life in patients

Downloads

Publicado

2013-06-30

Como Citar

Linden Junior, E. (2013). Abordagem Fisioterapêutica na Esclerose Lateral Amiotrófica:: Artigo de Atualização. Revista Neurociências, 21(2), 313–318. https://doi.org/10.34024/rnc.2013.v21.8188

Edição

Seção

Atualização

Artigos Semelhantes

1 2 3 4 5 6 7 8 9 10 > >> 

Você também pode iniciar uma pesquisa avançada por similaridade para este artigo.